How many insider trades does FilingIQ track for VREOF?

FilingIQ tracks 46 Form 4 insider transactions for VREOF (Vireo Growth Inc.), covering filings from Oct 10, 2024 onwards. 20 of those were filed in the last 90 days.

Are VREOF insiders net buyers or net sellers?

Across the full Form 4 history for VREOF, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does VREOF insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is VREOF in?

Vireo Growth Inc. (VREOF) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $457.29M.

VREOF insider trading

OTC Markets OTCQX Healthcare

Vireo Growth Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$457.29M

About Vireo Growth Inc.

Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024. Vireo Growth Inc. was incorporated in 2004 and is headquartered in Minneapolis, Minnesota.

Company website: www.vireogrowth.com

VREOF insider activity at a glance

FilingIQ has scored 46 insider transactions for VREOF since Oct 10, 2024. The most recent filing in our index is dated May 15, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live VREOF trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,147

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 185

Adaptive Biotechnologies Corp

GH 173

Guardant Health, Inc.

ISRG 169

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for VREOF?: FilingIQ tracks 46 Form 4 insider transactions for VREOF (Vireo Growth Inc.), covering filings from Oct 10, 2024 onwards. 20 of those were filed in the last 90 days.
Are VREOF insiders net buyers or net sellers?: Across the full Form 4 history for VREOF, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VREOF insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VREOF in?: Vireo Growth Inc. (VREOF) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $457.29M.

Methodology & sources

Every VREOF insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.